Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about ₹271 crore ($28.73 million).
Companies to follow
Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about ₹271 crore ($28.73 million).